Gianluigi Cetto - Academia.edu (original) (raw)
Uploads
Papers by Gianluigi Cetto
Journal of Clinical Oncology, Jun 1, 2005
678 Background: The rate of cell proliferation correlates with the response of breast cancer to c... more 678 Background: The rate of cell proliferation correlates with the response of breast cancer to chemotherapy and disease outcome. The Ki-67 protein is a useful histopathological marker for assessing the growth fraction of tumour cells during all of the active phases of the cell cycle. The measurement of Ki-67 levels by means of immunohistochemistry (MIB-1 antibody) is the most widely used method of evaluating cell proliferation and the biological aggressiveness of a tumour. High Ki-67 levels usually correlates with a poor prognosis in breast cancer. The aim of this study was to verify the relationshoip between Ki-67 levels and tumour characteristics. Patients and Methods: We analysed 3909 women who underwent surgery for an invasive breast tumour between 1992 and 2003, and correlated Ki-67 expression (low:0–15%; medium:16–25%; high:26–100%) with the clinical (menopausal status, disease presentation and age), biological (ER and PgR expression, c-erbB2 overexpression, and p53, p21 and bcl-2 expression) and p...
Tumori Journal, 1984
Prognosis and proper treatment in Hodgkin's disease (HD) are strictly related to staging accu... more Prognosis and proper treatment in Hodgkin's disease (HD) are strictly related to staging accuracy: liver and spleen involvement is of particular importance in this regard. We have evaluated, in 113 consecutive patients, the accuracy of clinical parameters to detect histologically documented HD involvement by comparing hepatosplenomegaly, liver function tests, liver and spleen scan, inspection of liver and spleen surface at laparoscopy with histologic findings. Our data suggest that of all the parameters studied, laparoscopy has the highest sensitivity and specificity values (about 100 %). Laparoscopy may precede laparotomy as a staging procedure in HD and may give, in patients not submitted to laparotomy whatever the reasons, very reliable information.
Tumori Journal, 2005
The aim of this short communication is to discuss the mechanism, modality and treatment of ifosfa... more The aim of this short communication is to discuss the mechanism, modality and treatment of ifosfamide encephalopathy. We present the case of a 52-year-old woman treated with this alkylating agent who developed severe neurotoxicity. It was resolved with administration of Methylene blue, abundant intravenous hydration and interruption of ifosfamide.
Journal of Clinical Oncology, 2005
771 Background: Tumour size and node involvement are the most important prognostic factors in bre... more 771 Background: Tumour size and node involvement are the most important prognostic factors in breast cancer (BC). Node-negative (N-) and T1 BCs usually have a better prognosis, but some of these patients experience a recurrence and die of systemic disease. Materials and Methods: We studied 1857 patients with invasive N- and T1 BCs to evaluate the importance of the tumour diameter and correlated it with pathological, biological and clinical parameters in order to define a subgroup of patients at higher risk of recurrence. T1a, T1b and T1c tumours were correlated with grading (G1, G2, G3), vascular invasion (VI) (positive vs negative), ER and PgR (positive vs negative), Ki-67 proliferative index (low 0–10%; intermediate 11–25%; high 26–100%), mammary family history (MF) (positive vs negative) and type of diagnosis (asymptomatic vs symptomatic). The data were analysed using the chi-squared test. Results: The larger lesions were associated with poor prognostic factors such as G3 (76.1% in T1c vs 18.1% in T1b ...
Journal of Clinical Oncology, 2005
678 Background: The rate of cell proliferation correlates with the response of breast cancer to c... more 678 Background: The rate of cell proliferation correlates with the response of breast cancer to chemotherapy and disease outcome. The Ki-67 protein is a useful histopathological marker for assessing the growth fraction of tumour cells during all of the active phases of the cell cycle. The measurement of Ki-67 levels by means of immunohistochemistry (MIB-1 antibody) is the most widely used method of evaluating cell proliferation and the biological aggressiveness of a tumour. High Ki-67 levels usually correlates with a poor prognosis in breast cancer. The aim of this study was to verify the relationshoip between Ki-67 levels and tumour characteristics. Patients and Methods: We analysed 3909 women who underwent surgery for an invasive breast tumour between 1992 and 2003, and correlated Ki-67 expression (low:0–15%; medium:16–25%; high:26–100%) with the clinical (menopausal status, disease presentation and age), biological (ER and PgR expression, c-erbB2 overexpression, and p53, p21 and bcl-2 expression) and p...
European Urology Supplements, 2008
European Journal of Cancer Supplements, 2004
European Journal of Cancer, 1995
European Journal of Cancer, 1999
European Journal of Cancer, 1993
Clinica Chimica Acta, 1974
... The standard RBC solutions (c,d) are slight modifications of those used by Funder and Wieth [... more ... The standard RBC solutions (c,d) are slight modifications of those used by Funder and Wieth [15], in order to avoid the photometric interference be-tween the cations. ... This study was supported by Consiglio Nazionale dell Ricerche, Rome, Italy. References 1 M. Maizels, Quart. ...
Breast Cancer Research and Treatment, 1995
Journal of Clinical Oncology, Jun 1, 2005
678 Background: The rate of cell proliferation correlates with the response of breast cancer to c... more 678 Background: The rate of cell proliferation correlates with the response of breast cancer to chemotherapy and disease outcome. The Ki-67 protein is a useful histopathological marker for assessing the growth fraction of tumour cells during all of the active phases of the cell cycle. The measurement of Ki-67 levels by means of immunohistochemistry (MIB-1 antibody) is the most widely used method of evaluating cell proliferation and the biological aggressiveness of a tumour. High Ki-67 levels usually correlates with a poor prognosis in breast cancer. The aim of this study was to verify the relationshoip between Ki-67 levels and tumour characteristics. Patients and Methods: We analysed 3909 women who underwent surgery for an invasive breast tumour between 1992 and 2003, and correlated Ki-67 expression (low:0–15%; medium:16–25%; high:26–100%) with the clinical (menopausal status, disease presentation and age), biological (ER and PgR expression, c-erbB2 overexpression, and p53, p21 and bcl-2 expression) and p...
Tumori Journal, 1984
Prognosis and proper treatment in Hodgkin's disease (HD) are strictly related to staging accu... more Prognosis and proper treatment in Hodgkin's disease (HD) are strictly related to staging accuracy: liver and spleen involvement is of particular importance in this regard. We have evaluated, in 113 consecutive patients, the accuracy of clinical parameters to detect histologically documented HD involvement by comparing hepatosplenomegaly, liver function tests, liver and spleen scan, inspection of liver and spleen surface at laparoscopy with histologic findings. Our data suggest that of all the parameters studied, laparoscopy has the highest sensitivity and specificity values (about 100 %). Laparoscopy may precede laparotomy as a staging procedure in HD and may give, in patients not submitted to laparotomy whatever the reasons, very reliable information.
Tumori Journal, 2005
The aim of this short communication is to discuss the mechanism, modality and treatment of ifosfa... more The aim of this short communication is to discuss the mechanism, modality and treatment of ifosfamide encephalopathy. We present the case of a 52-year-old woman treated with this alkylating agent who developed severe neurotoxicity. It was resolved with administration of Methylene blue, abundant intravenous hydration and interruption of ifosfamide.
Journal of Clinical Oncology, 2005
771 Background: Tumour size and node involvement are the most important prognostic factors in bre... more 771 Background: Tumour size and node involvement are the most important prognostic factors in breast cancer (BC). Node-negative (N-) and T1 BCs usually have a better prognosis, but some of these patients experience a recurrence and die of systemic disease. Materials and Methods: We studied 1857 patients with invasive N- and T1 BCs to evaluate the importance of the tumour diameter and correlated it with pathological, biological and clinical parameters in order to define a subgroup of patients at higher risk of recurrence. T1a, T1b and T1c tumours were correlated with grading (G1, G2, G3), vascular invasion (VI) (positive vs negative), ER and PgR (positive vs negative), Ki-67 proliferative index (low 0–10%; intermediate 11–25%; high 26–100%), mammary family history (MF) (positive vs negative) and type of diagnosis (asymptomatic vs symptomatic). The data were analysed using the chi-squared test. Results: The larger lesions were associated with poor prognostic factors such as G3 (76.1% in T1c vs 18.1% in T1b ...
Journal of Clinical Oncology, 2005
678 Background: The rate of cell proliferation correlates with the response of breast cancer to c... more 678 Background: The rate of cell proliferation correlates with the response of breast cancer to chemotherapy and disease outcome. The Ki-67 protein is a useful histopathological marker for assessing the growth fraction of tumour cells during all of the active phases of the cell cycle. The measurement of Ki-67 levels by means of immunohistochemistry (MIB-1 antibody) is the most widely used method of evaluating cell proliferation and the biological aggressiveness of a tumour. High Ki-67 levels usually correlates with a poor prognosis in breast cancer. The aim of this study was to verify the relationshoip between Ki-67 levels and tumour characteristics. Patients and Methods: We analysed 3909 women who underwent surgery for an invasive breast tumour between 1992 and 2003, and correlated Ki-67 expression (low:0–15%; medium:16–25%; high:26–100%) with the clinical (menopausal status, disease presentation and age), biological (ER and PgR expression, c-erbB2 overexpression, and p53, p21 and bcl-2 expression) and p...
European Urology Supplements, 2008
European Journal of Cancer Supplements, 2004
European Journal of Cancer, 1995
European Journal of Cancer, 1999
European Journal of Cancer, 1993
Clinica Chimica Acta, 1974
... The standard RBC solutions (c,d) are slight modifications of those used by Funder and Wieth [... more ... The standard RBC solutions (c,d) are slight modifications of those used by Funder and Wieth [15], in order to avoid the photometric interference be-tween the cations. ... This study was supported by Consiglio Nazionale dell Ricerche, Rome, Italy. References 1 M. Maizels, Quart. ...
Breast Cancer Research and Treatment, 1995